Quick Answer
BioScience Health Innovations, Inc. reported Total Revenue of $5.69 million for the year ending 2025.
- BioScience Health Innovations, Inc. showed an increase of +208.3% in Total Revenue from 2024 to 2025.
- This data is from BioScience Health Innovations, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $0.00 | Q4 2019: $0.00 | Q1 2020: $0.00 | Q2 2020: $0.00 | Q4 2020: $0.00 | Q1 2021: $0.00 | Q2 2021: $0.00 | Q4 2021: $0.00 | Q1 2022: $0.00 | Q1 2022: $279.00 | Q2 2022: $0.00 | Q2 2022: $8.0 thousand | Q3 2022: $19.7 thousand | Q4 2022: $0.00 | Q1 2023: $0.00 | Q1 2023: $32.3 thousand | Q2 2023: $69.5 thousand | Q3 2023: $192.2 thousand | Q1 2024: $277.6 thousand | Q2 2024: $384.2 thousand | Q3 2024: $573.0 thousand | Q1 2025: $1.23 million | Q2 2025: $1.76 million | Q3 2025: $1.13 million.
- Historical annual values: Fiscal year 2025: $5.69 million | Fiscal year 2024: $1.84 million | Fiscal year 2023: $597.6 thousand | Fiscal year 2022: $69.3 thousand | Fiscal year 2022: $0.00 | Fiscal year 2021: $0.00 | Fiscal year 2020: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: